Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E L Weinshel

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
CA: a Cancer Journal for Clinicians|November 1, 1993
Hodgkin's diseaseE L Weinshel, B A Peterson
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Ceftriaxone-associated neutropeniaA M Baciewicz, D J Skiest, E L Weinshel
Journal of Neuro-Oncology|August 1, 1991
Corynebacterium JK: a new pathogen in ventriculostomy infectionsV A Morrison, E L Weinshel, S D Luikart
Investigational New Drugs|December 16, 1998
Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trialR S Witte, J Manola, P A Burch, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
CA: a Cancer Journal for Clinicians|November 1, 1993
Hodgkin's diseaseE L Weinshel, B A Peterson
Drug Intelligence & Clinical Pharmacy|October 1, 1988
Ceftriaxone-associated neutropeniaA M Baciewicz, D J Skiest, E L Weinshel
Journal of Neuro-Oncology|August 1, 1991
Corynebacterium JK: a new pathogen in ventriculostomy infectionsV A Morrison, E L Weinshel, S D Luikart
Investigational New Drugs|December 16, 1998
Topotecan in previously treated advanced urothelial carcinoma: an ECOG phase II trialR S Witte, J Manola, P A Burch, et al.
Pageof 1